Anti-cancer activity of targeted pro-apoptotic peptides.
about
Appetizing rancidity of apoptotic cells for macrophages: oxidation, externalization, and recognition of phosphatidylserineCoupling endoplasmic reticulum stress to the cell death program: role of the ER chaperone GRP78Targeting of pro-apoptotic TLR adaptor SARM to mitochondria: definition of the critical region and residues in the signal sequenceA heterotypic bystander effect for tumor cell killing after adeno-associated virus/phage-mediated, vascular-targeted suicide gene transferTargeting neuropilin-1 in human leukemia and lymphomaStudies on anticancer activities of antimicrobial peptidesSuppression of murine collagen-induced arthritis by targeted apoptosis of synovial neovasculatureRoles of d-Amino Acids on the Bioactivity of Host Defense PeptidesPeptides as targeting probes against tumor vasculature for diagnosis and drug deliveryRecombinant IFN-α2a-NGR exhibits higher inhibitory function on tumor neovessels formation compared with IFN-α2a in vivo and in vitroThe potential of polymeric micelles in the context of glioblastoma therapy.Oncogenomics and the development of new cancer therapiesMitochondria as a target in treatmentChondroitin Sulfate as a Molecular Portal That Preferentially Mediates the Apoptotic Killing of Tumor Cells by Penetratin-directed Mitochondria-disrupting PeptidesTumorHoPe: a database of tumor homing peptidesAn antimicrobial peptidomimetic induces Mucorales cell death through mitochondria-mediated apoptosisRGDechi-hCit: αvβ3 selective pro-apoptotic peptide as potential carrier for drug delivery into melanoma metastatic cellsAn unrecognized extracellular function for an intracellular adapter protein released from the cytoplasm into the tumor microenvironment.The anti-angiogenic peptide anginex disrupts the cell membrane.NGR-peptide-drug conjugates with dual targeting properties.Enhanced cancer radiotherapy through immunosuppressive stromal cell destruction in tumorsThe use of therapeutic peptides to target and to kill cancer cells.Peptides from phage display library modulate gene expression in mesenchymal cells and potentiate osteogenesis in unicortical bone defects.Peptides selected for binding to clotted plasma accumulate in tumor stroma and wounds.Specialization of tumour vasculature.Orientation and helical conformation of a tissue-specific hunter-killer peptide in micelles.Recent advances in the development of anticancer agents targeting cell death inhibitors in the Bcl-2 protein family.Targeting the prostate for destruction through a vascular address.Molecular specialization of breast vasculature: a breast-homing phage-displayed peptide binds to aminopeptidase P in breast vasculature.Identification using phage display of peptides promoting targeting and internalization into HPV-transformed cell lines.Homing markers for atherosclerosis: applications for drug delivery, gene delivery and vascular imaging.Therapeutic cancer targeting peptides.Isolation of a colon tumor specific binding peptide using phage display selection.Development of a ligand-directed approach to study the pathogenesis of invasive aspergillosis.High-throughput screening of cell death inducible short peptides from TNF-related apoptosis-inducing ligand sequence.Display technologies: application for the discovery of drug and gene delivery agents.Combinatorial targeting of the macropinocytotic pathway in leukemia and lymphoma cells.IFATS collection: Combinatorial peptides identify alpha5beta1 integrin as a receptor for the matricellular protein SPARC on adipose stromal cells.Targeted induction of lung endothelial cell apoptosis causes emphysema-like changes in the mouse.A ligand peptide motif selected from a cancer patient is a receptor-interacting site within human interleukin-11.
P2860
Q23923115-FA4B3B26-E3E2-4B5D-8547-8A6113619DCAQ24293643-427213AB-AD27-4FB0-919F-840D2B2333AFQ24299063-8B107962-CDD6-4B0F-954D-9605A8846BA5Q24616181-D3A87CEE-D9BA-4A54-A40C-84CFF465AE1FQ24620098-8890A676-507C-46A8-AB69-6FFB1A956E2CQ24650885-1D1D0B3D-F4A7-4478-9344-54F3CF12794DQ24799893-9EE229D6-36F4-404A-9A0B-105B079E1382Q26744734-6949EC79-FCDF-4BBC-95D7-075F83AF05DEQ27024850-26B1B0E5-6688-4CDA-BB00-4CDC27CCD370Q27316848-76F61D36-26ED-4DE5-BEE2-7A656C5D3095Q27693205-DA244381-3E2A-4BD9-AFE8-62D84AAEA013Q28263634-00BD5B13-37F6-455B-AEBC-BA30A06C7FC8Q28382780-B8D8B6D7-636D-4FF5-86EF-11BABDAA9EA3Q28397647-AD7AB4EB-3BD3-4365-A4C9-0D1D82A86C85Q28482352-9773C70E-4BCA-46C5-A595-2F16D643915BQ28534020-ABE05793-7880-4D33-9EF2-38877E5BC736Q28543148-8639C73B-D918-47EC-8DE1-8B2178FF1E74Q30157382-D805503E-8AC4-4262-A30A-896F8EC28FADQ30159968-B5B38B3F-0FEE-464B-A72F-3B5630CBAC64Q30354486-4429255A-48AA-40B7-91EE-1716EBCC2317Q30408302-B08C26A2-B86B-4B4B-A754-4D566F348FACQ30418414-A9A9374E-58C9-481C-BE8D-05A3CFE13AF6Q30423413-87B93FA2-D508-40EB-AE90-E1C68B11790CQ30807745-F0C96F4E-7FC5-403B-87DD-FAC71B3C6368Q30896811-9F304677-5173-44BB-9AE0-4CC160AC0930Q30947036-71F2E74B-5678-4B52-8F9B-5ECD0C17C2D1Q30971455-946B2E5C-2FE6-4E2E-BA35-7CEF4E62D045Q31037658-1C3E1185-5781-4E8E-883F-89189FCA21EFQ31039259-E12C64F5-D4B7-4B55-933C-0DB8032C1E59Q31114638-BB02C26D-B5AF-4C65-B322-D8867884D606Q31880062-D887A14C-48D5-4A4B-9013-5AB32880E7EFQ33184888-341A18D9-C401-4E2A-9532-CCC0D2806223Q33195846-B97ABE7A-1445-4163-9F37-203E0C51E80FQ33225648-A90352D0-F7B5-4292-A1E4-B558A326BA28Q33232207-8C58D81F-6D3A-471B-9510-9A4092AB416FQ33264491-53F669FF-5526-468B-91E7-3B0F4D920F4FQ33320806-AD158CEB-B01C-47E5-9EEB-BF4FC1482F4DQ33347082-6BB8B8DA-20D5-4AF7-92C3-3D2EC148D19FQ33362288-7878C771-3583-450C-AAD3-BAD11AC037A8Q33378529-B58D48C6-448C-439E-BCBA-6E986582E43D
P2860
Anti-cancer activity of targeted pro-apoptotic peptides.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Anti-cancer activity of targeted pro-apoptotic peptides.
@en
type
label
Anti-cancer activity of targeted pro-apoptotic peptides.
@en
prefLabel
Anti-cancer activity of targeted pro-apoptotic peptides.
@en
P2093
P356
P1433
P1476
Anti-cancer activity of targeted pro-apoptotic peptides.
@en
P2093
Andrusiak R
Bredesen DE
Ellerby HM
Ellerby LM
Krajewski S
Lombardo CR
Pasqualini R
P2888
P304
P356
10.1038/12469
P407
P577
1999-09-01T00:00:00Z
P5875
P6179
1041418394